Article
[Disorders of sphingolipid activator proteins].
Nihon rinsho. Japanese journal of clinical medicine - 1 Dec 1995
Suzuki Y
Abstract excerpt
Small-molecular nonenzymatic glycoproteins are necessary for degradation of sphingolipids in lysosomes. GM2 activator encoded by a gene on chromosome 5 is essential for hydrolysis of ganglioside GM2 and its asialo derivative. Mutations of this gene cause Tay-Sachs disease-like clinical phenotype (GM2-gangliosidosis AB variant). Another gene on chromosome 10 codes for a protein called prosaposin, which is then...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
